You just read:

Biohaven Enrolls First Patient in Pivotal Trial of BHV-4157 in Patients With Hereditary Spinocerebellar Ataxia

News provided by

Biohaven Pharmaceutical Holding Company Ltd.

22 Dec, 2016, 03:00 ET